In a Relief from Royalty (RFR) valuation, the royalty rate is the single most influential assumption. A 1 percentage point change in the royalty rate can shift the asset value by 15-25%, depending on the revenue base and asset life. Everything else in the RFR calculation — the revenue forecast, discount rate, and useful life — may be perfectly calibrated, but if the royalty rate is wrong, the valuation is wrong.
The challenge is that royalty rates are not observable market prices in the way that, say, property yields or bond spreads are. They must be inferred from comparable licensing transactions, which are often privately negotiated, poorly documented, and may include bundled terms that complicate the extraction of a clean rate. This article provides a practical framework for finding, evaluating, and selecting defensible royalty rates.
A defensible royalty rate is not plucked from an industry range. It is derived from comparable transactions, adjusted for relevant differences, and cross-checked against economic logic. The documentation trail from comparable selection through adjustment to final rate is what makes a valuation audit-proof.
| Database | Coverage | Strengths | Limitations |
|---|---|---|---|
| RoyaltyStat | 20,000+ agreements from SEC filings | US-centric, detailed terms available | Limited non-US coverage |
| ktMINE | Global IP transactions | Broad industry coverage, analytics tools | Some agreements lack financial detail |
| Royalty Range | European and global | Good European coverage, industry segmentation | Smaller dataset than US databases |
| Bloomberg Terminal | M&A and licensing transactions | Integration with financial data | Licensing data not the primary focus |
| IPlytics | Patent licensing and standards | Strong for SEPs and technology patents | Narrow focus on patent licensing |
No single database is comprehensive. A thorough royalty rate analysis should consult multiple sources and cross-reference results. SEC filings in the US often contain the most detailed licensing terms because public companies must disclose material agreements.
Beyond databases, royalty rate evidence can come from:
Finding licensing transactions is only the first step. Each comparable must be assessed for its relevance to the asset being valued.
Is the licensed asset the same type as the asset being valued? A software licensing agreement is not comparable to a pharmaceutical patent licence, even if both are technology assets.
Licensing rates vary dramatically by industry. Software royalty rates (5-25%) are structurally different from consumer goods rates (2-8%) because of different margin structures.
Exclusive licences command higher rates than non-exclusive. Worldwide licences differ from territory-restricted deals. Bundled agreements (IP + services) must be unbundled.
A licence for a dominant market-leading technology will command a higher rate than one for a niche or commodity alternative. Assess the relative market power of licensor and licensee.
Raw comparable rates almost never apply directly. Common adjustments include:
| Adjustment | Direction | Rationale |
|---|---|---|
| Exclusivity | Up if exclusive, down if non-exclusive | Exclusive licences have higher value |
| Geographic scope | Up for broader territory | Worldwide rights are worth more |
| Bundled services | Down to remove service component | Isolate the pure IP rate |
| Upfront payments | Adjust to convert to running royalty equivalent | Some deals include lump sums |
| Cross-licensing | Down to net out reciprocal value | Cross-licences understate the true rate |
| Bargaining power | Adjust for relative negotiating position | Distressed licensors accept lower rates |
| Date of agreement | Consider market evolution | Older agreements may not reflect current conditions |
Adjustments should be documented and quantified wherever possible. Saying "we adjusted upward for exclusivity" is not sufficient — the magnitude of the adjustment and its basis must be explained. If adjustments become so large that the comparable is more adjustment than data, it may be better to exclude the comparable entirely.
While each valuation requires specific comparable analysis, industry benchmarks provide useful reference points and cross-checks:
| Industry / Asset Type | Typical Royalty Range | Basis |
|---|---|---|
| Enterprise software | 10-25% of revenue | Complexity, switching costs |
| Consumer software/apps | 5-15% of revenue | Competition, commoditisation |
| Pharmaceutical patents | 3-8% of net sales | Patent strength, therapeutic area |
| Medical devices | 3-7% of net sales | Regulatory barriers, alternatives |
| Consumer brands | 3-10% of revenue | Brand strength, category |
| Industrial technology | 2-6% of revenue | Process efficiency gains |
| Telecommunications | 1-5% of revenue | Standards-essential patents, FRAND |
| Media and entertainment | 5-15% of revenue | Content type, distribution rights |
A SaaS company's proprietary technology platform generates £30M in annual subscription revenue. Comparable licensing transactions for similar enterprise software platforms show royalty rates of 12-18%. After adjusting for exclusivity (the owner has sole use) and the platform's market-leading position, a rate of 15% is selected. This implies annual royalty savings of £4.5M, which would be projected over the technology's useful life and discounted to present value.
A selected royalty rate should be consistent with the economics of the asset. One useful cross-check is the profit split test: does the royalty rate imply a reasonable split of profits between the licensor (who owns the IP) and the licensee (who commercialises it)?
The "25% rule" (licensor receives 25% of the licensee's operating profit) was historically used as a benchmark but was rejected by the US Court of Appeals for the Federal Circuit in Uniloc v Microsoft (2011) as an unreliable starting point. Nevertheless, the underlying logic — that the rate should represent a reasonable sharing of economic benefit — remains sound as a cross-check.
The royalty rate should not exceed the licensee's EBITDA margin, since no rational licensee would pay a royalty that eliminates all profit. If the business has a 20% EBITDA margin and the selected royalty rate is 18% of revenue, the rate is almost certainly too high.
Royalty rate selection is the foundation of every RFR valuation. Build the rate from comparable transactions, adjust for relevant differences, and cross-check against economic logic and profit margins. Document every step of the analysis — from database search parameters through comparability assessment to final adjustments. The Opagio Calculator includes built-in royalty rate benchmarks by industry and asset type to support and cross-check your analysis.
Ivan Gowan is the Founder and CEO of Opagio. His experience licensing technology platforms at IG Group and across the fintech sector provides practical insight into the commercial dynamics that drive licensing rates. Meet the team.
Estimate the value of your intangible assets using industry-standard methods like Relief from Royalty, MPEEM, and With & Without.
A step-by-step guide to the Relief from Royalty method — the most widely used technique for valuing brands, trademarks, patents, and software. Learn the theory, the inputs, the royalty rate benchmarks, and how Opagio Intangibles runs a defensible RFR valuation across your full asset portfolio.
Read more →
How IP valuations work for lending — four accepted methods, IVS compliance requirements, what banks actually need, common failures, and how to get lending-ready.
Read more →
How to value trade names and trademarks using the Relief from Royalty method. Covers royalty rate selection for marketing-related intangibles, useful life considerations for brands, and the factors that distinguish a valuable trade name from a generic one.
Read more →Get the latest insights on intangible asset growth and productivity delivered to your inbox.
Book a free consultation to see how Opagio Intangibles can help your business.